medicine 📍 EU

M-M-RVaxPro

Analogs of M-M-RVaxPro

Find cheaper analogs and generic equivalents for M-M-RVaxPro.

Ingredients

ਸਰਗਰਮ ਤੱਤ: measles virus Enders� Edmonston strain (live, attenuated);mumps virus Jeryl Lynn (level B) strain (live, attenuated);rubella virus Wistar RA 27/3 strain (live, attenuated)

ਉਤਪਾਦ ਝਲਕ

About M-M-RVaxPro

M-M-RVaxPro is a vaccine used to protect adults and children aged 12 months or older against measles, mumps, and rubella (German measles). Under some special circumstances, it can also be used in babies as young as nine months. M-M-RVaxPro contains live attenuated (weakened) measles, mumps and rubella viruses.

What it is used for

M-M-RVaxPro is used to protect against measles, mumps, and rubella (German measles).

How it is used

M-M-RVaxPro is available as a powder and solvent that are made up into a suspension for injection. It is given as one dose injected into a muscle or under the skin, preferably in the thighs of younger children and the shoulder in older children and adults. For people with thrombocytopenia (low blood platelet counts) or any problems with blood clotting, the vaccine should only be injected under the skin to avoid bleeding. People who did not respond to the first dose can be given a second dose after at least four weeks. Babies between nine and 12 months can be given the vaccine if they are considered to be at special risk, for example, if there is an outbreak in a day-care centre or the baby is travelling to an area where measles is common. They should be re-vaccinated at between 12 and 15 months. They may also be given an additional vaccination against measles. The vaccine can only be obtained with a prescription. It is given according to official recommendations.

How it works

M-M-RVaxPro is a vaccine. Vaccines work by ‘teaching’ the immune system (the body’s natural defences) how to defend itself against a disease. M-M-RVaxPro contains small amounts of weakened forms of the viruses that cause measles, mumps, and rubella. When a person is given the vaccine, the immune system recognises the weakened viruses as ‘foreign’ and makes antibodies against them. In the future, the immune system will be able to produce antibodies more quickly when it is exposed to any of these viruses. This will help to protect against diseases caused by these viruses.

Active substance: Not specified.

Source: EMA EPAR